LINGO1 — Leucine-Rich Repeat and Immunoglobulin-Like Domain-Containing Neurite Outgrowth Inhibitor Protein

LINGO1 — Leucine-Rich Repeat and Immunoglobulin-Like Domain-Containing Neurite Outgrowth Inhibitor Protein

Introduction

Lingo1 — Leucine Rich Repeat And Immunoglobulin Like Domain Containing Neurite Outgrowth Inhibitor Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

LINGO1 — Leucine-Rich Repeat and Immunoglobulin-Like Domain-Containing Neurite Outgrowth Inhibitor Protein

Introduction

Lingo1 — Leucine Rich Repeat And Immunoglobulin Like Domain Containing Neurite Outgrowth Inhibitor Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene"> [@baetcher2008]
<table> [@rudick2009]
<tr><th colspan="2" style="background:#f8f9fa;text-align:center;font-size:1.2em;">LINGO1</th></tr> [@jepson2012]
<tr><td colspan="2" style="text-align:center;font-style:italic;">Leucine-Rich Repeat and Immunoglobulin-Like Domain-Containing Neurite Outgrowth Inhibitor Protein</td></tr> [@zhou2010]
<tr><th style="width:40%;">Gene Symbol</th><td>LINGO1</td></tr>
<tr><th>Full Name</th><td>Leucine-Rich Repeat and Immunoglobulin-Like Domain-Containing Neurite Outgrowth Inhibitor Protein</td></tr>
<tr><th>Chromosome</th><td>15q24.2</td></tr>
<tr><th>NCBI Gene ID</th><td>[158878](https://www.ncbi.nlm.nih.gov/gene/158878)</td></tr>
<tr><th>Ensembl ID</th><td>[ENSG00000130540](https://www.ensembl.org/Homo_species/Gene/Summary?g=ENSG00000130540)</td></tr>
<tr><th>OMIM</th><td>[609732](https://www.omim.org/entry/609732)</td></tr>
<tr><th>UniProt ID</th><td>[Q9BZN1](https://www.uniprot.org/uniprot/Q9BZN1)</td></tr>
<tr><th>Associated Diseases</th><td>Multiple Sclerosis, Parkinson's Disease, Alzheimer's Disease</td></tr>
<tr><th>Expression</th><td>Brain, Spinal Cord, Oligodendrocytes, [Neurons](/entities/neurons)</td></tr>
</table>
</div>

Overview

LINGO1 (Leucine-Rich Repeat and Immunoglobulin-Like Domain-Containing Neurite Outgrowth Inhibitor Protein) is a transmembrane protein that is a key negative regulator of axonal regeneration in the central nervous system. It is expressed predominantly in oligodendrocytes and neurons, where it inhibits neurite outgrowth and myelination.

Function

LINGO1 plays critical roles in nervous system development and repair:

• Negatively regulates oligodendrocyte differentiation and myelination
• Inhibits axonal regeneration after injury
• Forms a tripartite complex with Nogo-66 receptor (NgR1) and p75 neurotrophin receptor
• Blocks axon growth through the Nogo, MAG, and OMgp pathways
• Regulates neuronal survival and differentiation

Disease Associations

Multiple Sclerosis

LINGO1 is a major therapeutic target in MS:

• LINGO1 inhibitors promote remyelination in animal models
• Clinical trials of LINGO1 antibodies are ongoing
• Genetic variants may influence MS susceptibility

Parkinson's Disease

• LINGO1 may be involved in dopaminergic neuron survival
• Altered expression observed in PD models
• Potential therapeutic target

Alzheimer's Disease

• LINGO1 affects synaptic plasticity
• May interact with [tau](/proteins/tau) pathology
• Role in neuronal dysfunction

Therapeutic Implications

• LINGO1 antagonists (including monoclonal antibodies) are in clinical trials
• Promotes remyelination in preclinical models
• May enhance neural repair in various neurological conditions

Key Publications

See Also

• [Multiple Sclerosis](/diseases/multiple-sclerosis)
• [Myelin](/entities/myelin)
• [Axonal Regeneration](/entities/axonal-regeneration)
• [Parkinson's Disease](/diseases/parkinsons-disease)

External Links

• [NCBI Gene: LINGO1](https://www.ncbi.nlm.nih.gov/gene/158878)
• [UniProt: LINGO1](https://www.uniprot.org/uniprot/Q9BZN1)

CNS Regeneration

Axonal Regeneration Block

• Forms receptor complex with NgR1 and p75NTR
• Activates RhoA/ROCK signaling pathway
• Prevents axon outgrowth after injury
• Inhibits oligodendrocyte precursor differentiation

Myelination

• Prevents oligodendrocyte differentiation
• Inhibits myelin sheath formation
• Blocking LINGO1 enhances remyelination

Clinical Trials

Anti-LINGO1 Therapy

• Opicinumab (anti-LINGO1 antibody) in clinical trials
• Promising results for remyelination in MS
• Phase 2 trials showed improved conduction
• Ongoing research for optimal dosing

Protein Structure

LINGO1 is a transmembrane protein with distinct domains:

• Leucine-rich repeat (LRR) domain: Located extracellularly, mediates protein-protein interactions
• Immunoglobulin (Ig) domain: Contributes to ligand binding and receptor complex formation
• Transmembrane helix: Anchors the protein in the cell membrane
• Cytoplasmic tail: Contains motifs for signaling pathway activation

Expression Pattern

LINGO1 expression is developmentally regulated:

• High expression during embryonic development
• Declines in adulthood but remains in specific brain regions
• Expressed in oligodendrocyte precursor cells (OPCs)
• Present in neurons, especially in the [cortex](/brain-regions/cortex) and [hippocampus](/brain-regions/hippocampus)

Research Directions

Biomarker Potential

• LINGO1 expression may serve as a marker of demyelination
• Soluble LINGO1 detectable in cerebrospinal fluid
• Potential for disease monitoring

Combination Therapies

• LINGO1 antibodies with other remyelination strategies
• Enhancement of OPC differentiation
• Combination with neurotrophic factors

Background

The study of Lingo1 — Leucine Rich Repeat And Immunoglobulin Like Domain Containing Neurite Outgrowth Inhibitor Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References